Cutaneous blood-filled vesicles on idraparinux

The Lancet

Volumn 372, Issue 9654, 2008, Pages 1949-

  Benatar, J ^a   Stewart, RAH ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; IDRAPARINUX; WARFARIN;

DISEASE SEVERITY; HUMAN; LETTER; MEDICAL RESEARCH; PRIORITY JOURNAL; SKIN BLOOD VESSEL; SKIN DEFECT; SUBCUTANEOUS HEMORRHAGE;

EID: 57149101167     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61834-6     Document Type: Letter

References (5)

1. The Amadeus Investigators. Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 371 (2008) 315-321
2. Buller H.R., Cohen A.T., Davidson B., et al. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med 357 (2007) 1094-1104
3. ten Holder S.M., Joy M.S., and Falk R.J. Cutaneous and systemic manifestations of drug-induced vasculitis. Ann Pharmacother 36 (2002) 130-147
4. Bauer K.A., Eriksson B.I., Lassen M.R., and Turpie A.G. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345 (2001) 1305-1310
5. Buller H.R., Cohen A.T., Davidson B., et al. Extended prophylaxis of venous thromboembolism with idraparinux. N Engl J Med 357 (2007) 1105-1112